GSK Notifies Consumers of Product Tampering with Certain Bottles of OTC Weight-Loss Product Alli

By Pharma News - DCAT Publisher

March 26, 2014

GlaxoSmithKline (GSK) is alerting consumers that some bottles of its alli® over-the-counter weight loss medication have been tampered with. The company reports that it has started an investigation and is working with FDA. These tampered products were reportedly purchased by consumers at retail stores in the following seven states: Alabama, Florida, Louisiana, Mississippi, New York, North Carolina, and Texas.

GSK outlined what the tampered product looks like:

  • The outer carton may look authentic.
  • The bottle may contain a range of tablets and capsules of various shapes and colors.
  • The bottle may not have a label.
  • The bottle's tamper evident seal may not be intact, not be made of foil and/or not have the authentic alli® wording: "Sealed for your Protection."
  • The lot numbers and expiration dates on the bottle do not match the lot number and expiration date on the outer carton.
  • To date, some bottles bearing the following lot numbers and expiration dates on the carton have been reported to us by consumers as containing product other than alli®: 
  •      Carton Lot 14372, Expiration: 02/28/2016
  •      Carton Lot 14395, Expiration: 02/28/2016
  •      Carton Lot 14124, Expiration: 09/30/2015
  •      Carton Lot 14267, Expiration: 01/31/2016
  •      Carton Lot 14442, Expiration: 04/30/2016

Source: GlaxoSmithKline